Trump Names CDC Director Pick
April 17, 2026
By HealthDay Staff HealthDay ReporterFRIDAY, April 17, 2026 (HealthDay News) — After months of leadership changes, President Donald Trump has...
President Donald Trump announced his selection for the next director of the Centers for Disease Control and Prevention, tapping a former state health official known for her focus on reforming public health agencies and skepticism of widespread mandates. The choice of Dr. Evelyn Hayes signals the administration's intent to continue reshaping the nation's top public health agency, moving it toward what supporters call a more focused and accountable mission. The nomination comes at a critical time for the CDC, which has faced years of scrutiny and calls for reform from across the political spectrum following its central role in the COVID-19 pandemic.
Dr. Hayes, a physician who most recently served as a private health consultant, was previously the top public health official in a Republican-led state. There, she gained a reputation for prioritizing economic considerations alongside health outcomes and advocating for local control over public health decisions. Her supporters praise her as a much-needed reformer who can streamline the CDC, enhance transparency, and focus the agency on its core function of fighting infectious diseases, a goal aligned with the administration's "Make America Healthy Again" initiative. Proponents argue she will bring a fresh perspective and necessary fiscal discipline to an agency they believe has become bloated and overextended.
However, the nomination has been met with immediate concern from many public health experts and Democratic lawmakers. They worry Dr. Hayes's track record suggests a willingness to prioritize politics and business interests over scientific integrity, potentially weakening the agency's ability to respond to future health crises. Critics point to her past questioning of certain federal guidelines as evidence that she may not fully support the robust, independent scientific leadership they argue is essential for the CDC's mission. These groups advocate for strengthening public health infrastructure and view the nomination as a step in the opposite direction.
The selection is the latest development in an ongoing debate over the future of public health in the United States. Following the pandemic, Republican leaders in the Senate launched a working group to examine legislative reforms for the CDC, citing a loss of public trust and a need to prevent what they termed "bureaucratic overreach." This nomination is seen by many as the executive branch's parallel effort to implement a similar vision, one that emphasizes deregulation, state-level decision-making, and a narrower scope for federal health agencies.
The nomination now proceeds to the Senate for confirmation, a process that became mandatory for the CDC Director role starting in 2025. The confirmation hearings in the Senate Health, Education, Labor, and Pensions Committee are expected to be contentious, serving as a platform for a broader national debate on the role of government in public health. The outcome will not only determine the leadership of a vital national security asset but will also offer a clear indication of the administration's health policy direction for the remainder of its term.
Source: usnews